CLIA Kit for Glial Fibrillary Acidic Protein (GFAP)

Intermediate Filament Protein

  • CLIA Kit for Glial Fibrillary Acidic Protein (GFAP) Packages (Simulation)
  • CLIA Kit for Glial Fibrillary Acidic Protein (GFAP) Packages (Simulation)
  • CLIA Kit for Glial Fibrillary Acidic Protein (GFAP) Results demonstration
  • SCA068Ra.jpg Typical Standard Curve
  • Certificate ISO9001: 2008, ISO13485: 2003 Registered

Specificity of the CLIA Kit for Glial Fibrillary Acidic Protein (GFAP)

This assay has high sensitivity and excellent specificity for detection of Glial Fibrillary Acidic Protein (GFAP).
No significant cross-reactivity or interference between Glial Fibrillary Acidic Protein (GFAP) and analogues was observed.

Recovery of the CLIA Kit for Glial Fibrillary Acidic Protein (GFAP)

Matrices listed below were spiked with certain level of recombinant Glial Fibrillary Acidic Protein (GFAP) and the recovery rates were calculated by comparing the measured value to the expected amount of Glial Fibrillary Acidic Protein (GFAP) in samples.

Matrix Recovery range (%) Average(%)
serum(n=5) 84-91 87
EDTA plasma(n=5) 81-91 85
heparin plasma(n=5) 94-103 101

Precision of the CLIA Kit for Glial Fibrillary Acidic Protein (GFAP)

Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Glial Fibrillary Acidic Protein (GFAP) were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level Glial Fibrillary Acidic Protein (GFAP) were tested on 3 different plates, 8 replicates in each plate.
CV(%) = SD/meanX100
Intra-Assay: CV<10%
Inter-Assay: CV<12%

Linearity of the CLIA Kit for Glial Fibrillary Acidic Protein (GFAP)

The linearity of the kit was assayed by testing samples spiked with appropriate concentration of Glial Fibrillary Acidic Protein (GFAP) and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.

Sample 1:2 1:4 1:8 1:16
serum(n=5) 91-99% 96-104% 95-103% 97-104%
EDTA plasma(n=5) 87-94% 89-96% 93-101% 83-94%
heparin plasma(n=5) 81-94% 80-99% 86-102% 86-95%

Stability of the CLIA Kit for Glial Fibrillary Acidic Protein (GFAP)

The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition.
To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.

Assay procedure summary of the CLIA Kit for Glial Fibrillary Acidic Protein (GFAP)

1. Prepare all reagents, samples and standards;
2. Add 100µL standard or sample to each well. Incubate 1 hours at 37°C;
3. Aspirate and add 100µL prepared Detection Reagent A. Incubate 1 hour at 37°C;
4. Aspirate and wash 3 times;
5. Add 100µL prepared Detection Reagent B. Incubate 30 minutes at 37°C;
6. Aspirate and wash 5 times;
7. Add 100µL Substrate Solution. Incubate 10 minutes at 37°C;
8. Read RLU value immediately.

Test principle of the CLIA Kit for Glial Fibrillary Acidic Protein (GFAP)

The microplate provided in this kit has been pre-coated with an antibody specific to Glial Fibrillary Acidic Protein (GFAP). Standards or samples are then added to the appropriate microplate wells with a biotin-conjugated antibody specific to Glial Fibrillary Acidic Protein (GFAP). Next, Avidin conjugated to Horseradish Peroxidase (HRP) is added to each microplate well and incubated. Then the mixture of substrate A and B is added to generate glow light emission kinetics. Upon plate development, the intensity of the emitted light is proportional to the Glial Fibrillary Acidic Protein (GFAP) level in the sample or standard.;

Related products

Catalog No. Organism species: Rattus norvegicus (Rat) Applications (RESEARCH USE ONLY!)
RPA068Ra02 Recombinant Glial Fibrillary Acidic Protein (GFAP) Positive Control; Immunogen; SDS-PAGE; WB.
RPA068Ra01 Recombinant Glial Fibrillary Acidic Protein (GFAP) Positive Control; Immunogen; SDS-PAGE; WB.
PAA068Ra02 Polyclonal Antibody to Glial Fibrillary Acidic Protein (GFAP) WB; IHC; ICC; IP.
PAA068Ra01 Polyclonal Antibody to Glial Fibrillary Acidic Protein (GFAP) WB; IHC; ICC; IP.
LAA068Ra71 Biotin-Linked Polyclonal Antibody to Glial Fibrillary Acidic Protein (GFAP) WB; IHC; ICC.
LAA068Ra81 FITC-Linked Polyclonal Antibody to Glial Fibrillary Acidic Protein (GFAP) WB; IHC; ICC; IF.
MAA068Ra24 Monoclonal Antibody to Glial Fibrillary Acidic Protein (GFAP) WB; IHC; ICC; IP.
MAA068Ra25 Monoclonal Antibody to Glial Fibrillary Acidic Protein (GFAP) WB; IHC; ICC; IP.
MAA068Ra23 Monoclonal Antibody to Glial Fibrillary Acidic Protein (GFAP) WB; IHC; ICC; IP.
MAA068Ra22 Monoclonal Antibody to Glial Fibrillary Acidic Protein (GFAP) WB; IHC; ICC; IP.
MAA068Ra21 Monoclonal Antibody to Glial Fibrillary Acidic Protein (GFAP) WB; IHC; ICC; IP.
SEA068Ra ELISA Kit for Glial Fibrillary Acidic Protein (GFAP) Enzyme-linked immunosorbent assay for Antigen Detection.
SCA068Ra CLIA Kit for Glial Fibrillary Acidic Protein (GFAP) Chemiluminescent immunoassay for Antigen Detection.
LMA068Ra Magnetic Luminex Assay Kit for Glial Fibrillary Acidic Protein (GFAP) Magnetic Luminex Assay for Antigen Detection.
KSA068Ra01 ELISA Kit DIY Materials for Glial Fibrillary Acidic Protein (GFAP) Main materials for "Do It (ELISA Kit) Yourself".
CGA068Ra02 cDNA of Glial Fibrillary Acidic Protein (GFAP) PCR; Protein Expression; etc.
GUESTBOOK